The role of TRADD in TRAIL-induced apoptosis and signaling

Xiumei Cao1, Yelena L Pobezinskaya, Michael J Morgan

  • 1Cell and Cancer Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

Insights

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) signaling involves TRADD for cell survival. TRADD limits FADD binding, reducing cancer cell apoptosis and impacting TRAIL-based cancer therapies.

Area of Science:

  • Cellular and Molecular Biology
  • Immunology
  • Oncology

Background:

  • TRAIL induces cancer cell apoptosis, making it a promising anticancer therapy.
  • TRAIL signaling pathways, particularly the roles of adaptor proteins like TRADD and RIP1, are not fully understood.
  • TRADD's function in TRAIL-induced apoptosis has been controversial.

Purpose of the Study:

  • To investigate the role of TRADD in TRAIL-mediated apoptosis.
  • To elucidate the molecular mechanisms by which TRADD influences TRAIL signaling.
  • To determine the implications of TRADD's function for TRAIL-based cancer therapies.

Main Methods:

  • Utilized wild-type and Tradd(-/-) mouse embryonic fibroblasts (MEFs) and primary keratinocytes.
  • Assessed TRAIL-induced apoptosis sensitivity using recombinant mouse TRAIL (rmTRAIL) and cycloheximide (CHX).
  • Investigated protein recruitment to the TRAIL-receptor complex using biochemical assays and analyzed MAP kinase ERK activation.

Main Results:

  • Tradd(-/-) MEFs exhibited hypersensitivity to TRAIL-induced apoptosis compared to wild-type MEFs.
  • TRADD recruitment to the TRAIL-receptor complex was demonstrated, mediating RIP1 recruitment.
  • TRADD deficiency led to increased FADD recruitment and reduced early ERK activation, enhancing TRAIL sensitivity.

Conclusions:

  • TRADD plays a crucial survival role in TRAIL signaling by limiting FADD binding and mediating RIP1-dependent nonapoptotic pathways.
  • TRADD's function in regulating apoptosis has significant implications for the development of TRAIL-receptor agonists in cancer treatment.
  • Understanding TRADD's role can help optimize TRAIL-based therapies to overcome resistance and enhance efficacy.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...